CAPR - This is a fantastic chart from the FDA deramiocel review, showing how unauthorized changes to the HOPE-3 study statistical plan led t

CAPR - This is a fantastic chart from the FDA deramiocel review, showing how unauthorized changes to the HOPE-3 study statistical plan led to dramatic increases in statistical significance. If your study delivers negative results, change the way you analyze the results! -- ADAM F STAT